Company: BCDRF
Filing Date: 2025-02-28
Form Type: 20-F
Source: 0000891478-25-000054
Chunk: 594

Company: Banco Santander, S.A.
Filing Date: 2025-02-28
Form: 20-F
Chunk 594
---
 balance sheets as of 31 December 2024, 2023 and 2022513

Consolidated income statements for the years ended 31 December 2024, 2023 and 2022517

Consolidated statements of recognised income and expense for the years ended 31 December 2024, 2023 and 2022519

Consolidated statements of changes in total equity for the years ended 31 December 2024, 2023 and 2022520

Consolidated statements of cash flows for the years ended 31 December 2024, 2023 and 2022526

### Notes to the consolidated financial statements 588
1. Introduction, basis of presentation of the consolidated financial statements (consolidated annual accounts) and other information 589

2. Accounting policies 594

3. Grupo Santander 620

4. Distribution of Banco Santander’s profit, shareholder remuneration scheme and earnings per share 624

5. Remuneration and other benefits paid to the Bank’s directors and senior managers 626

6. Loans and advances to central banks and credit institutions 639

7. Debt securities 640

8. Equity instruments 642

9. Trading derivatives (assets and liabilities) and short positions 643

10. Loans and advances to customers 643

11. Trading derivatives 649

12. Non-current assets 649

13. Investments 649

14. Insurance contracts linked to pensions 651

15. Liabilities under insurance contracts 652

16. Tangible assets 653

17. Intangible assets - Goodwill 656

18. Intangible assets - Other intangible assets 659

19. Other assets 660

20. Deposits from central banks and credit institutions 661

21. Customer deposits 661

22. Marketable debt securities 662

23. Subordinated liabilities 665

24. Other financial liabilities 669

25. Provisions 670

26. Other liabilities 687

27. Tax matters 688

28. Non-controlling interests 695

29. Other comprehensive income 696

30. Shareholders' equity 702

31. Issued capital 702

32. Share premium 704

33. Accumulated retained earnings 704

34. Other equity instruments and own shares 705

35. Memorandum items 706

36. Hedging derivatives 706

37. Discontinued operations 731

38. Interest income 731